Literature DB >> 20937441

Prehypertension: an opportunity for a new public health paradigm.

Brent M Egan1, Daniel T Lackland, Daniel W Jones.   

Abstract

From 2005 to 2006, approximately 3 of 8 adults in the United States had blood pressure (BP) in the prehypertensive range of 120 to 139/80 to 89 mm Hg and roughly 1 in 8 adults had BP in the range of 130 to 139/85 to 89 mm Hg, which is referred to as high normal BP or stage 2 prehypertension. Adults with stage 2 prehypertension are also roughly twice as likely as adults with normotension to suffer cardiovascular disease. The Seventh Report of the Joint National Committee on Hypertension recommended only lifestyle changes for most prehypertensive patients. BP in the range of 120 to 129/80 to 84 mm Hg is also associated with increased risk but roughly half of that of stage 2 prehypertension.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937441     DOI: 10.1016/j.ccl.2010.07.008

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  12 in total

Review 1.  Prehypertension--prevalence, health risks, and management strategies.

Authors:  Brent M Egan; Sean Stevens-Fabry
Journal:  Nat Rev Cardiol       Date:  2015-02-17       Impact factor: 32.419

2.  Progression is accelerated from prehypertension to hypertension in blacks.

Authors:  Anbesaw Selassie; C Shaun Wagner; Marilyn L Laken; M LaFrance Ferguson; Keith C Ferdinand; Brent M Egan
Journal:  Hypertension       Date:  2011-09-12       Impact factor: 10.190

3.  Screening low-income women of reproductive age for cardiovascular disease risk factors.

Authors:  Cheryl L Robbins; Thomas C Keyserling; Stephanie B Jilcott Pitts; John Morrow; Nadya Majette; Jessica A Sisneros; Ashley Ronay; Sherry L Farr; Rachel Peragallo Urrutia; Patricia M Dietz
Journal:  J Womens Health (Larchmt)       Date:  2013-03-26       Impact factor: 2.681

4.  Moderately elevated blood pressure during pregnancy and odds of hypertension later in life: the POUCHmoms longitudinal study.

Authors:  G L Dunietz; K L Strutz; C Holzman; Y Tian; D Todem; B L Bullen; J M Catov
Journal:  BJOG       Date:  2017-02-25       Impact factor: 6.531

5.  Differential Impact of Stress Reduction Programs upon Ambulatory Blood Pressure among African American Adolescents: Influences of Endothelin-1 Gene and Chronic Stress Exposure.

Authors:  Mathew J Gregoski; Vernon A Barnes; Martha S Tingen; Yanbin Dong; Haidong Zhu; Frank A Treiber
Journal:  Int J Hypertens       Date:  2011-11-24       Impact factor: 2.420

6.  Prehypertension and incidence of cardiovascular disease: a meta-analysis.

Authors:  Yuli Huang; Sheng Wang; Xiaoyan Cai; Weiyi Mai; Yunzhao Hu; Hongfeng Tang; Dingli Xu
Journal:  BMC Med       Date:  2013-08-02       Impact factor: 8.775

7.  Efficacy of a church-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members: a randomized controlled trial in Pretoria, South Africa.

Authors:  Supa Pengpid; Karl Peltzer; Linda Skaal
Journal:  BMC Public Health       Date:  2014-06-06       Impact factor: 3.295

8.  Prevalence and risk factors associated with prehypertension in Shunde District, southern China.

Authors:  Yuli Huang; Wenke Qiu; Changhua Liu; Dingji Zhu; Jinghai Hua; Xiaoyan Cai; Yanxian Wu; Yunzhao Hu; Dingli Xu
Journal:  BMJ Open       Date:  2014-11-13       Impact factor: 2.692

Review 9.  Prehypertension is not associated with all-cause mortality: a systematic review and meta-analysis of prospective studies.

Authors:  Xiaofan Guo; Xiaoyu Zhang; Liqiang Zheng; Liang Guo; Zhao Li; Shasha Yu; Hongmei Yang; Xinghu Zhou; Lu Zou; Xingang Zhang; Zhaoqing Sun; Jue Li; Yingxian Sun
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

10.  Rural-to-urban migration and risk of hypertension: longitudinal results of the PERU MIGRANT study.

Authors:  A Bernabe-Ortiz; J F Sanchez; R M Carrillo-Larco; R H Gilman; J A Poterico; R Quispe; L Smeeth; J J Miranda
Journal:  J Hum Hypertens       Date:  2016-02-11       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.